MCID: SPR005
MIFTS: 37

Superficial Basal Cell Carcinoma malady

Cancer diseases category

Aliases & Classifications for Superficial Basal Cell Carcinoma

About this section

Aliases & Descriptions for Superficial Basal Cell Carcinoma:

Name: Superficial Basal Cell Carcinoma 8 61
Multifocal Superficial Basal Cell Carcinoma 8 61
 
Superficial Multicentric Basal-Cell Carcinoma 8
Multicentric Basal Cell Carcinoma 8


Classifications:



External Ids:

Disease Ontology8 DOID:4300
SNOMED-CT56 61098004
NCIt39 C4108

Summaries for Superficial Basal Cell Carcinoma

About this section
MalaCards based summary: Superficial Basal Cell Carcinoma, also known as multifocal superficial basal cell carcinoma, is related to basal cell carcinoma and melanoma. An important gene associated with Superficial Basal Cell Carcinoma is DLL1 (delta-like 1 (Drosophila)), and among its related pathways are Presenilin action in Notch and Wnt signaling and Neural Crest Differentiation. The compounds ginsenoside and dacarbazine have been mentioned in the context of this disorder. Affiliated tissues include skin and t cells, and related mouse phenotypes are hearing/vestibular/ear and renal/urinary system.

Related Diseases for Superficial Basal Cell Carcinoma

About this section

Graphical network of the top 20 diseases related to Superficial Basal Cell Carcinoma:



Diseases related to superficial basal cell carcinoma

Symptoms for Superficial Basal Cell Carcinoma

About this section

Drugs & Therapeutics for Superficial Basal Cell Carcinoma

About this section

Drug clinical trials:

Search ClinicalTrials for Superficial Basal Cell Carcinoma

Search NIH Clinical Center for Superficial Basal Cell Carcinoma

Genetic Tests for Superficial Basal Cell Carcinoma

About this section

Anatomical Context for Superficial Basal Cell Carcinoma

About this section

MalaCards organs/tissues related to Superficial Basal Cell Carcinoma:

31
Skin, T cells

Animal Models for Superficial Basal Cell Carcinoma or affiliated genes

About this section

MGI Mouse Phenotypes related to Superficial Basal Cell Carcinoma:

35
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053778.3NOTCH1, DLL1, BCL2, JAG1
2MP:00053678.3JAG1, BCL2, DLL1, NOTCH1
3MP:00053818.2JAG1, BCL2, DLL1, NOTCH1
4MP:00053698.2NOTCH1, DLL1, BCL2, JAG1
5MP:00053798.1NOTCH1, DLL1, BCL2, JAG1
6MP:00053978.1NOTCH1, DLL1, BCL2, JAG1
7MP:00107718.0MME, JAG1, BCL2, NOTCH1
8MP:00053857.8JAG1, BCL2, DLL1, NOTCH1
9MP:00053767.7MME, JAG1, BCL2, DLL1, NOTCH1

Publications for Superficial Basal Cell Carcinoma

About this section

Articles related to Superficial Basal Cell Carcinoma:

(show top 50)    (show all 101)
idTitleAuthorsYear
1
Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted delivery of topical fluorouracil. (25687314)
2015
2
Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal. (25581584)
2015
3
The role of the 595-nm pulsed dye laser in treating superficial basal cell carcinoma: outcome of a double-blind randomized placebo-controlled trial. (25040296)
2014
4
Immunocryosurgery for Non-superficial Basal Cell Carcinoma: A Pro-spective, Open-label Phase III Study for Tumours a8oa882 cm in Diameter. (23722308)
2014
5
A case of scrotal superficial basal cell carcinoma caused by chronic arsenic exposure. (24566581)
2014
6
Superficial basal cell carcinoma successfully treated with ingenol mebutate gel 0.05% (25052730)
2014
7
Aesthetic evaluation after non-invasive treatment for superficial basal cell carcinoma. (22103716)
2013
8
Dermal changes in superficial basal cell carcinoma, melanoma in situ and actinic keratosis and their implications. (24117926)
2013
9
Spoke wheel-like structures in superficial basal cell carcinoma: a correlation between dermoscopy, histopathology, and reflective confocal microscopy. (24124839)
2013
10
Combined Carbon Dioxide Laser with Photodynamic Therapy for Nodular and Superficial Basal Cell Carcinoma: Almost Scarless Cure With Minimal Recurrence. (23407256)
2013
11
Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial. (22964973)
2012
12
Chronicle of a pigmented superficial Basal cell carcinoma. (23259087)
2012
13
Effectiveness and satisfaction with imiquimod for the treatment of superficial basal cell carcinoma in daily dermatological practice. (21348896)
2011
14
Large superficial Basal cell carcinoma arising in the scalp. (22028585)
2011
15
A comparison in real clinical practice of methyl aminolevulinate photodynamic therapy and surgery for small superficial basal cell carcinoma: 3-year recurrence rates and cosmetic outcomes. (20456551)
2011
16
PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial. (20546215)
2010
17
Large superficial basal cell carcinoma arising from moxa cautery. (19451052)
2009
18
Superficial basal cell carcinoma treated with imiquimod 5% topical cream for a 4-week period: a case series. (19646136)
2009
19
Vitiligo-like depigmentation induced by imiquimod treatment of superficial basal cell carcinoma. (19659986)
2009
20
Management of superficial basal cell carcinoma: focus on imiquimod. (21436969)
2009
21
A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. (18624836)
2008
22
Microscopic distribution of protoporphyrin (PpIX) fluorescence in superficial basal cell carcinoma during light-fractionated aminolaevulinic acid photodynamic therapy. (19002337)
2008
23
Dermoscopic patterns of superficial basal cell carcinoma. (18986346)
2008
24
Giant superficial basal cell carcinoma treated with cryosurgery. (18657160)
2008
25
Primary superficial basal cell carcinoma of the nipple. (17684426)
2007
26
Induction of the members of Notch pathway in superficial basal cell carcinomas treated with imiquimod. (17922128)
2007
27
CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma. (18032951)
2007
28
5% 5-Fluorouracil cream for the treatment of small superficial Basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. (17430377)
2007
29
Radial streaking: unusual dermoscopic pattern in pigmented superficial basal cell carcinoma. (17894724)
2007
30
Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks. (17034468)
2006
31
Superficial basal cell carcinoma on face treated with 5% imiquimod cream. (17050935)
2006
32
Superficial basal cell carcinoma of the scalp mimicking seborrhoeic dermatitis. (16428215)
2006
33
Management of primary superficial basal cell carcinoma. (16751865)
2006
34
Clinical and histopathologic findings of superficial basal cell carcinoma: A comparison with other basal cell carcinoma subtypes. (16970272)
2006
35
Dermoscopic monitoring of tazarotene treatment of superficial basal cell carcinoma. (15762218)
2005
36
Giant superficial basal cell carcinoma of the scrotum. (15908305)
2005
37
595 nm pulsed dye laser for the treatment of superficial basal cell carcinoma. (16328096)
2005
38
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. (15888150)
2005
39
A case of penile superficial basal cell carcinoma involving the inner surface of foreskin. (16303075)
2005
40
5% imiquimod cream for the treatment of large superficial basal cell carcinoma. (15492202)
2004
41
Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD4 T cells and dendritic cells. (15550144)
2004
42
Evidence that superficial basal cell carcinoma is monoclonal from analysis of the Ptch1 gene locus. (12410703)
2002
43
Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. (11312429)
2001
44
Ber-EP4-positive phenotype differentiates actinic keratosis from superficial basal cell carcinoma. (10816226)
2000
45
Guess what! Superficial basal cell carcinoma of the scrotum. (10408920)
1999
46
Therapeutic options for superficial basal cell carcinoma: the role of radiation therapy. (9645651)
1998
47
Photodynamic therapy of superficial basal cell carcinoma by instillation of aminolevulinic acid and irradiation with visible light. (9420532)
1997
48
SUPERFICIAL BASAL-CELL CARCINOMA. (14191739)
1964
49
The histological findings in normal skin and multiple superficial basal cell carcinoma treated with an ointment containing demecolcine. (14406310)
1959
50
Superficial Basal-cell Carcinoma. (19992640)
1943

Variations for Superficial Basal Cell Carcinoma

About this section

Expression for genes affiliated with Superficial Basal Cell Carcinoma

About this section
Search GEO for disease gene expression data for Superficial Basal Cell Carcinoma.

Pathways for genes affiliated with Superficial Basal Cell Carcinoma

About this section

Pathways related to Superficial Basal Cell Carcinoma according to GeneCards Suite gene sharing:

(show all 13)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.4NOTCH1, DLL1
29.4NOTCH1, DLL1
3
Show member pathways
9.3NOTCH1, JAG1
49.3JAG1, NOTCH1
59.0NOTCH1, BCL2
6
Show member pathways
8.9JAG1, DLL1, NOTCH1
7
Show member pathways
Notch signaling pathway36
8.9JAG1, DLL1, NOTCH1
88.9NOTCH1, DLL1, JAG1
9
Show member pathways
8.9NOTCH1, DLL1, JAG1
10
Show member pathways
Delta-Notch Signaling Pathway36
Notch Signaling Pathway36
8.9NOTCH1, DLL1, JAG1
11
Show member pathways
Development Notch Signaling Pathway59
Transcription Sin3 and NuRD in transcription regulation59
8.9NOTCH1, DLL1, JAG1
12
Show member pathways
8.6NOTCH1, DLL1, BCL2
138.1NOTCH1, DLL1, BCL2, JAG1

Compounds for genes affiliated with Superficial Basal Cell Carcinoma

About this section

Compounds related to Superficial Basal Cell Carcinoma according to GeneCards Suite gene sharing:

(show all 28)
idCompoundScoreTop Affiliating Genes
1ginsenoside449.6MME, BCL2
2dacarbazine44 1110.5BCL2, IFNA1
32-chlorodeoxyadenosine449.5IFNA1, BCL2
4mitoxantrone44 50 1111.4BCL2, IFNA1
5fludarabine44 50 1111.4BCL2, IFNA1
6rituximab44 50 1111.4IFNA1, BCL2
7vinblastine44 50 1111.4IFNA1, BCL2
8thymidylate449.4BCL2, IFNA1
9vincristine44 50 1111.3IFNA1, BCL2
10camptothecin44 60 1111.3BCL2, IFNA1
11quercetin44 60 24 1112.3BCL2, MME
12docetaxel44 50 60 1112.2BCL2, IFNA1
13cyclophosphamide44 50 1111.1IFNA1, BCL2
14nitric oxide44 24 1111.1MME, NOTCH1, JAG1
15cytarabine44 50 1111.1MME, BCL2, IFNA1
16adriamycin449.0IFNA1, BCL2, MME
17actinomycin d449.0MME, IFNA1, BCL2
18cycloheximide449.0MME, BCL2, IFNA1
19rapamycin448.8NOTCH1, IFNA1, BCL2
20imatinib44 50 1110.8IFNA1, BCL2
21phosphatidylinositol448.8BCL2, MME, NOTCH1
22oxygen44 249.6MME, NOTCH1, BCL2
23estrogen448.5MME, NOTCH1, BCL2
24doxorubicin44 50 1110.4NOTCH1, IFNA1, MME, BCL2
25dexamethasone44 50 28 1111.4MME, IFNA1, BCL2, NOTCH1
26vegf448.4NOTCH1, BCL2, IFNA1, MME
27retinoic acid44 249.4NOTCH1, BCL2, IFNA1, MME
28serine448.3BCL2, NOTCH1, IFNA1, MME

GO Terms for genes affiliated with Superficial Basal Cell Carcinoma

About this section

Biological processes related to Superficial Basal Cell Carcinoma according to GeneCards Suite gene sharing:

(show all 25)
idNameGO IDScoreTop Affiliating Genes
1loop of Henle developmentGO:00720709.9JAG1, DLL1
2cell fate determinationGO:00017099.8DLL1, JAG1
3compartment pattern specificationGO:00073869.8NOTCH1, DLL1
4positive regulation of Notch signaling pathwayGO:00457479.7JAG1, DLL1
5left/right axis specificationGO:00709869.7NOTCH1, DLL1
6distal tubule developmentGO:00720179.7NOTCH1, JAG1
7negative regulation of stem cell differentiationGO:020007379.7JAG1, NOTCH1
8cardiac septum morphogenesisGO:00604119.7NOTCH1, JAG1
9pulmonary valve morphogenesisGO:00031849.6NOTCH1, JAG1
10Notch signaling involved in heart developmentGO:00613149.6NOTCH1, JAG1
11response to muramyl dipeptideGO:00324959.6JAG1, NOTCH1
12determination of left/right symmetryGO:00073689.6NOTCH1, DLL1
13heart loopingGO:00019479.6DLL1, NOTCH1
14hemopoiesisGO:00300979.4JAG1, DLL1
15keratinocyte differentiationGO:00302169.4NOTCH1, JAG1
16mesenchymal cell developmentGO:00140319.4BCL2, NOTCH1
17neuronal stem cell maintenanceGO:00971509.3NOTCH1, DLL1, JAG1
18Notch receptor processingGO:00072209.3NOTCH1, DLL1, JAG1
19negative regulation of ossificationGO:00302799.3NOTCH1, BCL2
20negative regulation of anoikisGO:020008119.3NOTCH1, BCL2
21Notch signaling pathwayGO:00072199.2JAG1, DLL1, NOTCH1
22hair follicle morphogenesisGO:00310699.2NOTCH1, BCL2
23humoral immune responseGO:00069599.0NOTCH1, BCL2
24positive regulation of transcription from RNA polymerase II promoterGO:00459448.9NOTCH1, DLL1, JAG1
25axonogenesisGO:00074098.7NOTCH1, BCL2

Molecular functions related to Superficial Basal Cell Carcinoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1Notch bindingGO:00051129.2DLL1, JAG1
2calcium ion bindingGO:00055098.9NOTCH1, DLL1, JAG1

Sources for Superficial Basal Cell Carcinoma

About this section
2CDC
12ExPASy
13FDA
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
51PubMed
52QIAGEN
57SNOMED-CT via Orphanet
61UMLS
62UMLS via Orphanet